VIENNA — The use of immunosuppressive and antifibrotic drugs to treat skin and lung fibrosis leads updated recommendations from the European Alliance of Associations for Rheumatology […]

VIENNA (Reuters) – The Taliban-ordered crash in opium production in Afghanistan, long the world’s dominant supplier, could drive up overdose deaths as heroin users switch to […]

MONTREAL —Tirzepatide (Mounjaro, Eli Lilly), the dual gastric inhibitory polypeptide–glucagon-like peptide 1 (GIP–GLP-1) receptor agonist that has shown significant benefits in diabetes and obesity, may also […]

New data from the landmark FLOW trial, which linked the glucagon peptide 1 (GLP-1) receptor agonist semaglutide with significant kidney outcomes in patients with type 2 […]

Adults older than 50 years who report experiencing persistently high levels of loneliness have a 56% increased risk for stroke, a new study showed. The increased […]

When the National Institutes of Health (NIH) launched a $1 billion dollar research effort in 2021 focused on long COVID, hopes were high that it would […]

In a cross-sectional study of malpractice and medical liability claims for cutaneous energy-based device procedures, the most litigated health professionals were plastic surgeons, and the most […]